A carregar...

Current statuses of molecular targeted and immune checkpoint therapies in hepatocellular carcinoma

Treatment of advanced hepatocellular carcinoma (HCC) still confronts great challenges due to high rate of therapeutic resistance. The emergence of systemic treatment with molecular targeted and immune checkpoint therapies has brought novel approaches towards patients with advanced HCC. However, sora...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Cancer Res
Main Authors: Kong, Deqiang, Liu, Chen, Miao, Xiaolong, Wang, Yao, Ding, Xianfeng, Gong, Weihua
Formato: Artigo
Idioma:Inglês
Publicado em: e-Century Publishing Corporation 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7269783/
https://ncbi.nlm.nih.gov/pubmed/32509395
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!